Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CASP3 |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → CASP3 |
| (<<) CSNK1D → CASP3 |
| (<<) EIF4E → CASP3 |
| (<<) FOS → CASP3 |
| (<<) HYAL1 → CASP3 |
| (<<) KCNK1 → CASP3 |
| (<<) MYLK → CASP3 |
| (<<) SEPW1 → CASP3 |
| (<<) UBE2D3 → CASP3 |
| (<<) YWHAB → CASP3 |
| Downstream (Children) |
|---|
| CASP3 → ARAF (>>) |
| CASP3 → ATP2C1 (>>) |
| CASP3 → CASP7 (>>) |
| CASP3 → CDK7 (>>) |
| CASP3 → CDKN2A (>>) |
| CASP3 → CEBPB (>>) |
| CASP3 → HEY1 (>>) |
| CASP3 → IL1A (>>) |
| CASP3 → MUC2 (>>) |
| CASP3 → MYL5 (>>) |
| CASP3 → PDK2 (>>) |
| CASP3 → PTGS2 (>>) |
| CASP3 → RBP1 (>>) |
| CASP3 → RCOR1 (>>) |
| CASP3 → SEH1L (>>) |
| CASP3 → SMAD2 (>>) |
| CASP3 → TNFRSF11A (>>) |
| CASP3 → VANGL1 (>>) |
